fig4

CF10/LV overcomes acquired resistance to 5-FU/LV in colorectal cancer cells through downregulation of the c-Myc/ABCB5 axis

Figure 4. Myc is elevated in 5-FU/LV-resistant HCT116R cells, but CF10/LV decreases levels of Myc and the Myc-target ABCB5 at both the protein and mRNA levels. (A) Western blot for Myc with quantification of the Western blot image by densitometry shown in (B) and quantification of mRNA levels by RT-qPCR shown in (C). (D) Western blot for ABCB5 with quantification of the Western blot image by densitometry shown in (E) and quantification of mRNA levels by RT-qPCR shown in (F). *P < 0.03, **P < 0.002, ***P < 0.0002, ****P < 0.0001. Figure preparation software is GraphPad Prism (RRID: SCR_002798). 5-FU: 5-Fluorouracil; LV: leucovorin; RT-qPCR: reverse transcription quantitative polymerase chain reaction.

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/